Source information only5 / 25 / 50 mg
Three historical catalog entries
Dosage form, manufacturer and package are not specified. Review FDA withdrawal information and ask the pharmacy about the exact product’s status.
Explore pharmacy listings
Hormone health · Clinic product catalog
Oxandrolonefor Your Clinic.
Review the oxandrolone entries in the supplied source catalog alongside important FDA withdrawal information. Catalog inclusion does not establish current availability or an approved product.
The source entries are retained for review, with no assurance of current supply.
✓
Source details. Regulatory context. Product review.One connected portal for your practice.
01 Explore product options02 Review pharmacy details03 Order through your account
Your product options
Read the source with its regulatory context.
Optimal’s source contains 5 mg, 25 mg and 50 mg names. These entries are retained for information; they are not presented as current approved products or an offer to supply.
Illustrative packaging. Actual appearance and packaging vary.
Compare the exact listing
Review the FDA noticeExplore by pharmacy.
3 source entries. Open a pharmacy to review its listings. Repeated or similar names do not establish distinct products or current availability.
Optimal3 listings
| Source preparation / review note | Listed strength / specification | Package |
|---|---|---|
| Oxandrolone 25mgSource information only — review FDA withdrawal context | 25mg | Not specified — confirm |
| Oxandrolone 50mgSource information only — review FDA withdrawal context | 50mg | Not specified — confirm |
| Oxandrolone 5mgSource information only — review FDA withdrawal context | 5mg | Not specified — confirm |
Before you order
The product details that matter.
Review the exact product with the responsible pharmacy before submitting an order.
- Source ingredient
- Oxandrolone
- Source named amounts
- 5, 25 and 50 mg
- Catalog pharmacy
- Optimal
- Dosage form & package
- Not established by the source
- Regulatory review
- FDA withdrawal notices require specific attention
- Availability
- Not established; this page is source information only
Source review01 / IDENTIFY 02 / REVIEW 03 / CONFIRM
Clarify the current product status.
Check the source entry.
Confirm ingredient, dosage form, manufacturer and package.
Read the FDA context.
Review the relevant withdrawal notices and current requirements.
Ask the pharmacy.
A catalog entry is not an assurance of approval, eligibility or supply.
Product contextClinical information,
Clinical information,
with clear sources.
The treating clinician determines suitability and prescribing. Review the exact product’s labeling and pharmacy information.
Oxandrolone is an anabolic steroid with significant regulatory history. The supplied catalog entries do not establish that any current product may be supplied.
FDA withdrawal information is central.
FDA withdrew approval of specified Oxandrin and generic oxandrolone tablet applications in 2023. Its October 2026 correction confirms safety-or-effectiveness withdrawal findings for the referenced 2.5 mg and 10 mg products and applications. Different catalog amounts do not establish approval or resolve those concerns. FDA / Federal Register: oxandrolone withdrawal correction
Confirm the regulatory status of the exact preparation. Compounded drugs are not FDA-approved and do not undergo FDA premarket review for safety, effectiveness or quality. FDA: compounded drug information
Sources checked October 19, 2026. This page provides product information, not diagnosis, treatment selection, dosing or administration instructions.
Useful answers
Oxandrolone product FAQs.
Does this page mean oxandrolone is available to order?
No. This page preserves the supplied source information and explains the FDA withdrawal context. It does not confirm availability, approval or eligibility for supply or compounding.
How many pharmacy entries are represented?
This page represents 3 source entries. Some names may overlap; confirm the exact product and current availability through your approved account.
Are strengths and concentrations patient doses?
No. Product amounts, concentrations and package quantities describe different specifications. The clinician and dispensing pharmacy determine the prescription and instructions.
Are products from different pharmacies interchangeable?
Interchangeability is not established by a shared ingredient name, matching concentration or release abbreviation. Review each complete formulation and label.
Are all products on this page FDA-approved?
No approval status is established by catalog inclusion. Compounded preparations are not FDA-approved. Confirm the exact product and regulatory status with the pharmacy.
Can patients place orders directly?
This is an informational source page and does not offer this product for sale. Patients should discuss treatment with their clinician.
What should my clinic check before reordering?
Review the current ingredient list, strength units, dosage form, route, release characteristics, package, availability, storage and applicable pharmacy requirements.
How can my clinic contact CoreLink?
Email info@corelinkpharm.com for platform and account questions. Contact the pharmacy for product-specific information.
Ready to review products for your clinic?
Contact CoreLink with platform questions. Ask the pharmacy about exact product identity and current status.